Document is current
Any future updates will be listed below
-
Authors
Hasselholm, Emma B. https://orcid.org/0000-0002-1017-7702
Just, Jesper https://orcid.org/0000-0002-3825-0000
Chang, Simon https://orcid.org/0000-0003-1130-3659
Skakkebæk, Anne https://orcid.org/0000-0001-9178-4901
Gravholt, Claus Højbjerg https://orcid.org/0000-0001-5924-1720
-
Funding
Funding for this research was provided by:
Danmarks Frie Forskningsfond (2096-00165A)
Aarhus Universitet
Danish Diabetes and Endocrine Academy
Familien Hede Nielsens Fond
Novo Nordisk Fonden (NNF20OC0060610)
Sygesikring Danmark (2022-0189)
- License Information
-
More Information
Article History
Received: 4 February 2025
Accepted: 22 August 2025
First Online: 1 September 2025
Declarations
:
: All DNAm data used in this study have previously been published (ClinicalTrials.gov NCT00624949, NCT00999310, NCT02526628, and NCT01678261). All clinical investigations were conducted according to the principles expressed in the Declaration of Helsinki.
: The authors declare no competing interests.
